ArticleJournal of cardiothoracic surgery2026
Exploring the application value of preoperative femoral artery and vein cannulation in redo cardiac surgery.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo explore the clinical value of preoperative femoral vessel cannulation in redo cardiac surgery.
methodsA retrospective analysis was performed on the clinical data of 106 patients who underwent redo cardiac surgery in our hospital from January 2022 to December 2024. According to the cardiopulmonary bypass (CPB) cannulation technique adopted, the patients were divided into the Femoral Cannulation group (n = 79) and the Traditional Central Cannulation group (n = 37). Preoperative baseline data, intraoperative CPB-related parameters, blood product consumption, and the incidence of postoperative complications were recorded and compared between the two groups.
resultsThere were no statistically significant differences in preoperative baseline data or intraoperative parameters between the two groups (all P > 0.05). Similarly, no significant statistical differences were found in postoperative mortality, extracorporeal membrane oxygenation (ECMO) utilization rate, acute kidney injury (AKI) incidence, or cognitive dysfunction incidence between the two groups. However, compared with the Traditional Central Cannulation group, the Femoral Cannulation group had significantly lower intraoperative packed red blood cell (PRBC) transfusion volume and a significantly lower incidence of major cardiovascular injuries (all P < 0.05).
conclusionIn redo cardiac surgery, preoperative femoral vessel cannulation can significantly reduce the incidence of major cardiovascular injuries and the demand for intraoperative blood transfusion, which is worthy of promotion and application in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.